These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Skoien R; Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; O'Brien PE; Tilg H; Moschen AR; Baumann U; Brown RM; Couper RT; Manton ND; Ee LC; Weltman M; Clouston AD Liver Int; 2013 Apr; 33(4):624-32. PubMed ID: 23356584 [TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease. Leclercq I Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266 [TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666 [TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620 [TBL] [Abstract][Full Text] [Related]
9. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Bosserhoff A; Hellerbrand C Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223 [TBL] [Abstract][Full Text] [Related]
11. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Castera L Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184 [TBL] [Abstract][Full Text] [Related]
12. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
13. [Fatty liver and global cardiometabolic risk]. Szollár L Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306 [TBL] [Abstract][Full Text] [Related]
14. Current and future therapeutic strategies in NAFLD. Mark N; de Alwis W; Day CP Curr Pharm Des; 2010 Jun; 16(17):1958-62. PubMed ID: 20370671 [TBL] [Abstract][Full Text] [Related]
15. An adipocentric view of liver fibrosis and cirrhosis. Chuang JH; Wang PW; Tai MH Chang Gung Med J; 2004 Dec; 27(12):855-68. PubMed ID: 15754775 [TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y; Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062 [TBL] [Abstract][Full Text] [Related]
18. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280 [TBL] [Abstract][Full Text] [Related]
19. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Bataller R; Rombouts K; Altamirano J; Marra F Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741 [TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?]. Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]